Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Laboratorios Vijosa is a leading pharmaceutical company based in El Salvador and a dominant player in the Central American healthcare market. Founded in 1971, the company specializes in the development, manufacture, and commercialization of high-quality generic and over-the-counter (OTC) medications. Vijosa is best known for its flagship brand, Viro-Grip, which is a household name for treating cold and flu symptoms across the region. The company operates the Mega Planta Vijosa, one of the most technologically advanced pharmaceutical manufacturing facilities in Latin America, featuring high levels of automation and adherence to international Good Manufacturing Practices (GMP). Their extensive portfolio includes more than 600 products, ranging from antibiotics and analgesics to vitamins and injectable treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vijosa.